首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1729277

日本精準醫療市場報告（按產品、技術、應用（腫瘤學、中樞神經系統、免疫學、呼吸醫學、感染等）、最終用戶和地區）2025 年至 2033 年

Japan Precision Medicine Market Report by Product, Technology, Application (Oncology, Central Nervous System, Immunology, Respiratory Medicine, Infections, and Others), End User, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本精準醫療市場規模達48.55億美元。展望未來， IMARC Group預計到2033年市場規模將達到73.74億美元，2025-2033年期間的成長率（CAGR）為4.8%。遠距醫療和遠端監控技術的需求不斷成長，這主要推動著市場的發展，這些技術可以持續收集和分析資料，從而使醫療保健提供者能夠根據個人患者的資料即時調整治療計劃。

精準醫療是指一種創新的醫療保健方法，根據患者獨特的環境、遺傳和生活方式因素，為其量身定做醫療和干涉措施。與傳統的「一刀切」方法不同，精準醫療認知到每個人的基因組成和生活環境都是不同的。透過分析一個人的基因圖譜和其他相關資料，醫療保健提供者可以做出更準確的診斷，預測疾病風險並制定個人化治療計劃。這種方法不僅可以使治療更有效，而且可能更安全，因為它可以最大限度地減少副作用。精準醫療在腫瘤學等各個醫學領域顯示出良好的效果，其中可以設計針對性療法來專門對抗癌細胞，同時保護健康組織。它還可應用於心臟病學、神經病學和精神病學等領域，幫助最佳化從心臟病到精神疾病等各種疾病的治療。精準醫療的最終目標是透過提供客製化、高效、以患者為中心的解決方案來改善治療結果和生活品質，從而徹底改變醫療保健。

日本精準醫療市場趨勢：

日本精準醫療在醫療健康領域發展動能快速。有多種因素推動著其成長。首先，基因組學和生物技術的進步為更深入了解疾病的遺傳基礎鋪平了道路。這些知識促進了有針對性的治療的發展，從而改善了患者的治療效果。此外，日本慢性病發生率的上升也是一個重要促進因素。精準醫療有望提供更有效的治療和更好的疾病管理，從而有可能減輕醫療保健系統的負擔。此外，政府對精準醫療研發的措施和資金支持也扮演關鍵角色。政策制定者認知到精準醫療在降低醫療成本和改善病患照護方面的潛力，從而增加了對該領域的投資。除此之外，巨量資料和高級分析工具的廣泛應用，結合電子健康記錄、基因組資料和臨床資訊，可以提供更精確的診斷和治療建議，預計將在預測期內推動日本的精準醫療發展。

日本精準醫療市場細分：

產品洞察：

耗材
儀器
服務

技術洞察：

巨量資料分析
生物資訊學
基因定序
藥物研發
伴隨診斷
其他

應用程式洞察：

腫瘤學
中樞神經系統（CNS）
免疫學
呼吸內科
感染
其他

最終用戶洞察：

醫院和診所
診斷中心
製藥和生物技術公司
醫療保健IT公司
其他

競爭格局：

市場研究報告也對市場競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、頂級制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本精準醫療市場目前表現如何？未來幾年將如何表現？
新冠疫情對日本精準醫療市場有何影響？
日本精準醫療市場依產品分類是怎樣的？
日本精準醫療市場依技術分類的分佈如何？
日本精準醫療市場按應用分類的分佈如何？
根據最終用戶，日本精準醫療市場是如何分類的？
日本精準醫療市場的價值鏈分為哪些階段？
日本精準醫療的關鍵促進因素和挑戰是什麼？
日本精準醫療市場的結構是怎麼樣的？主要參與者有哪些？
日本精準醫療市場的競爭程度如何？

本報告回答的關鍵問題：

日本精準醫療市場目前表現如何？未來幾年將如何表現？
新冠疫情對日本精準醫療市場有何影響？
日本精準醫療市場依產品分類是怎樣的？
日本精準醫療市場依技術分類的分佈如何？
日本精準醫療市場按應用分類的分佈如何？
根據最終用戶，日本精準醫療市場是如何分類的？
日本精準醫療市場的價值鏈分為哪些階段？
日本精準醫療的關鍵促進因素和挑戰是什麼？
日本精準醫療市場的結構是怎麼樣的？主要參與者有哪些？
日本精準醫療市場的競爭程度如何？

Japan precision medicine market size reached USD 4,855 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7,374 Million by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The increasing demand for telemedicine and remote monitoring technologies, which allow for continuous data collection and analysis, thereby enabling healthcare providers to make real-time adjustments to treatment plans based on individual patient data, is primarily driving the market.

Precision medicine refers to an innovative healthcare approach that tailors medical treatment and interventions to individual patients based on their unique environmental, genetic, and lifestyle factors. Unlike traditional one-size-fits-all approaches, precision medicine recognizes that each person's genetic makeup and life circumstances are distinct. By analyzing a person's genetic profile and other relevant data, healthcare providers can make more accurate diagnoses, predict disease risk, and personalize treatment plans. This approach allows for treatments that are not only more effective but also potentially safer, as they minimize adverse effects. Precision medicine has shown promising results in various medical fields, such as oncology, where targeted therapies can be designed to specifically combat cancer cells while sparing healthy tissue. It also has applications in areas like cardiology, neurology, and psychiatry, helping to optimize treatments for ailments ranging from heart disease to mental health disorders. Ultimately, precision medicine aims to revolutionize healthcare by delivering tailored, efficient, and patient-centered solutions that improve outcomes and quality of life.

Japan Precision Medicine Market Trends:

The precision medicine in Japan is rapidly gaining momentum in the healthcare industry. Several drivers are propelling its growth. Firstly, advancements in genomics and biotechnology have paved the way for a deeper understanding of the genetic basis of diseases. This knowledge has enabled the development of targeted therapies, leading to improved patient outcomes. Moreover, the increasing incidence of chronic diseases in Japan is a significant driver. Precision medicine offers the promise of more efficacious treatments and better disease management, potentially reducing the burden on healthcare systems. Additionally, government initiatives and funding support for precision medicine R&D are playing a pivotal role. Policymakers recognize the potential of precision medicine to reduce healthcare costs and improve patient care, leading to increased investments in this field. Apart from this, the inflating application of big data and advanced analytics tools with the integration of electronic health records, genomic data, and clinical information that allow for more precise diagnosis and treatment recommendations is expected to drive the precision medicine in Japan during the forecast period.

Japan Precision Medicine Market Segmentation:

Product Insights:

Consumables
Instruments
Services

Technology Insights:

Big Data Analytics
Bioinformatics
Gene Sequencing
Drug Discovery
Companion Diagnostics
Others

Application Insights:

Oncology
Central Nervous System (CNS)
Immunology
Respiratory Medicine
Infections
Others

End User Insights:

Hospitals and Clinics
Diagnostic Centers
Pharma and Biotech Companies
Healthcare IT Firms
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan precision medicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan precision medicine market?
What is the breakup of the Japan precision medicine market on the basis of product?
What is the breakup of the Japan precision medicine market on the basis of technology?
What is the breakup of the Japan precision medicine market on the basis of application?
What is the breakup of the Japan precision medicine market on the basis of end user?
What are the various stages in the value chain of the Japan precision medicine market?
What are the key driving factors and challenges in the Japan precision medicine?
What is the structure of the Japan precision medicine market and who are the key players?
What is the degree of competition in the Japan precision medicine market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Precision Medicine Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Precision Medicine Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Precision Medicine Market - Breakup by Product

6.1 Consumables
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Services
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)

7 Japan Precision Medicine Market - Breakup by Technology

7.1 Big Data Analytics
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Bioinformatics
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Gene Sequencing
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Drug Discovery
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Companion Diagnostics
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2019-2024)
- 7.6.2 Market Forecast (2025-2033)

8 Japan Precision Medicine Market - Breakup by Application

8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Central Nervous System (CNS)
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Immunology
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Respiratory Medicine
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Infections
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2019-2024)
- 9.6.2 Market Forecast (2025-2033)

9 Japan Precision Medicine Market - Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Diagnostic Centers
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Pharma and Biotech Companies
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Healthcare IT Firms
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
9.5 Others
- 9.5.1 Historical and Current Market Trends (2019-2024)
- 9.5.2 Market Forecast (2025-2033)

10 Japan Precision Medicine Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Precision Medicine Market - Industry Analysis

12.1 Drivers, Restraints and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis